newsfilter
← Latest News
Business Wire·

Cyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer's Disease

– Biologic similarities demonstrated between Niemann-Pick Disease Type C and Alzheimer's disease, including cholesterol accumulation in regions of the brain, elevated levels of Tau in CSF, and amyloid plaques in the